The Typhoid Antibody Testing Market is expected to grow on a substantial note in the next 10 years. Geographies all across are into the creation of clinical mobility programs, wherein there would be appropriate coordination between the patients and individuals involved in the healthcare ecosystem. They are inclusive of radiologists, lab technicians, pharmacists, physicians, nurses, and likewise.
According to the latest research by Persistence Market Research, the Typhoid antibody testing market is set to witness a growth of 7.7% during the forecast period. Demand for Typhoid antibody testing expects to witness steady recovery in the short-term, with an optimistic growth outlook in the long run. The growing advancement for the Typhoid antibody testing industry will offer lucrative opportunities in near future.
Typhoid is a mosquito borne bacterial infection which is caused by unhygienic and infected food and drinking water. The usual symptoms for this disease are fever, vomiting and diarrhea.
Typhoid fever is most common in the developing countries where there are substandard levels of sanitation and drinking water facilities. There was an estimation of typhoid fever cases number of 540 in every 1,00,000 people.
The key drivers which can be accounted for the Typhoid antibody testing demand are the increasing number of typhoid cases globally. In a report published by WHO, every year around 22 million cases of typhoid fever are recorded all over the world, out of which nearly 2 lakh people die of the disease.
Get Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/32745
The high prevalence of this disease is the most important driver which is positively affecting the growing demand of this diagnosis market.
The rising incidence and mortality of typhoid fever has led the governments all over the world to increase its efforts to manage the number of cases in their respective regions, raise awareness about typhoid fever, and the development of nursing facilities.
All these factors are improving the global typhoid diagnosis demand. It is projected that new players in the market will bring strong competition to the global Typhoid antibody testing market during the forecast period.
The increasing prevalence of infectious diseases and the possibility of causing outbreaks or epidemics are the main reasons why the infectious disease sector in the antibody testing market has the highest growth potential during the forecast period.
While non-communicable diseases are the leading cause of death in developed countries, infectious diseases remain a key problem because they can evolve into large epidemics, as seen in the COVID19 pandemic.
US and Canada are one of the developed countries in the world. Hence, there are proper sanitation facilities along with proper sources of drinking water and food. For these reasons, there is a very low prevalence of typhoid cases in this region.
Get A Customized Scope To Match Your Need Ask An Expert – sales@persistencemarketresearch.com
According to WHO, only 300 cases per year are usually recorded in this region. There is a very low market demand and growth for Typhoid antibody testing in this region.
The Typhoid antibody testing market in Europe is also highly based on the developed healthcare infrastructure and having excellent levels of basic sanitation facilities. Since it is also a developed region, typhoid cases are rare in these countries. According to WHO, Europe records a staggering low case number of 500 per year.
Whereas, in developing countries like China, India, Nepal, Laos, Bangladesh and Vietnam record over 80% of cases of typhoid in the world. Thus, there is a huge market for typhoid antibody testing in these countries.
Some of the key manufacturers operating in the Typhoid antibody testing market are,
- NanoEnTek
- Medical Innovation Ventures
- IDL Biotech AB
- Linear Chemicals SLU
- Rapikit.com
- Malaysian Bio-diagnostic Research
- Siemens Healthcare GmbH
- Thermo Fisher Scientific
- Biosystems S.A.
- Biotec (Novacyt Group)
- Dialab GmbH.
The testing kits are used by the services providers, globally. Some of the major contributors in this field are Quest Diagnostics, SRL Diagnostics, Dr.Lal Pathlabs, Abbott Diagnostics, Vijaya Diagnostic Center, CSA labs and Apollo Diagnostics.
Access Full Report@ https://www.persistencemarketresearch.com/checkout/32745
Key Segments:
By Product Type:
- WIDAL Test
- Typhidot Test
- Rapid Serological Tests
- Counter Immunoelectrophoresis
- Hem-agglutination and Co-aggulation
- Enzyme-linked Immunosorbent Assays (ELISA)
- Dot Enzyme Immunoassay (DOT EIA)
By End –User:
- Serological Testing Centers
- Hospitals
- Diagnostic Centers
- Clinics
- Other Healthcare Facilities
By Region:
- North America
- Latin America
- Europe
- East Asia
- South Asia
- Oceania
- Middle East and Africa
About us: Persistence Market Research
Contact us:
Persistence Market Research
Address – 305 Broadway, 7th Floor, New York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com